Showing codes J7634 (Budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligram) — J7682 (Tobramycin, inhalation solution, fda-approved final product, non-compounded, unit dose form, administered through dme, per 300 milligrams)

J7634 - Budesonide comp con
Long description: Budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligram
Code added date: 20070101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7635 - Atropine comp con
Long description: Atropine, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
Code added date: 20000101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7636 - Atropine comp unit
Long description: Atropine, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
Code added date: 20000101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7637 - Dexamethasone comp con
Long description: Dexamethasone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
Code added date: 20000101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7638 - Dexamethasone comp unit
Long description: Dexamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
Code added date: 20000101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7639 - Dornase alfa non-comp unit
Long description: Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
Code added date: 20000101.
Code effective date: 20090101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7640 - Formoterol comp unit
Long description: Formoterol, inhalation solution, compounded product, administered through dme, unit dose form, 12 micrograms
Code added date: 20060101.
Code effective date: 20070101.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7641 - Flunisolide comp unit
Long description: Flunisolide, inhalation solution, compounded product, administered through dme, unit dose, per milligram
Code added date: 20020101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7642 - Glycopyrrolate comp con
Long description: Glycopyrrolate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
Code added date: 20000101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7643 - Glycopyrrolate comp unit
Long description: Glycopyrrolate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
Code added date: 20000101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7644 - Ipratropium bromide non-comp
Long description: Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
Code added date: 20000101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7645 - Ipratropium bromide comp
Long description: Ipratropium bromide, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
Code added date: 20070101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7647 - Isoetharine comp con
Long description: Isoetharine hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
Code added date: 20070101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7648 - Isoetharine non-comp con
Long description: Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram
Code added date: 20000101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7649 - Isoetharine non-comp unit
Long description: Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
Code added date: 20000101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7650 - Isoetharine comp unit
Long description: Isoetharine hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
Code added date: 20070101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7657 - Isoproterenol comp con
Long description: Isoproterenol hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
Code added date: 20070101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7658 - Isoproterenol non-comp con
Long description: Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram
Code added date: 20000101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7659 - Isoproterenol non-comp unit
Long description: Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
Code added date: 20000101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7660 - Isoproterenol comp unit
Long description: Isoproterenol hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
Code added date: 20070101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7665 - Mannitol for inhaler
Long description: Mannitol, administered through an inhaler, 5 mg
Code added date: 20120101.
Code effective date: 20130101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7667 - Metaproterenol comp con
Long description: Metaproterenol sulfate, inhalation solution, compounded product, concentrated form, per 10 milligrams
Code added date: 20070101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7668 - Metaproterenol non-comp con
Long description: Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 10 milligrams
Code added date: 20000101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7669 - Metaproterenol non-comp unit
Long description: Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams
Code added date: 20000101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7670 - Metaproterenol comp unit
Long description: Metaproterenol sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams
Code added date: 20070101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7674 - Methacholine chloride, neb
Long description: Methacholine chloride administered as inhalation solution through a nebulizer, per 1 mg
Code added date: 20050101.
Code effective date: 20050101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7676 - Pentamidine comp unit dose
Long description: Pentamidine isethionate, inhalation solution, compounded product, administered through dme, unit dose form, per 300 mg
Code added date: 20080101.
Code effective date: 20080101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7677 - Revefenacin inh non-com 1mcg
Long description: Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram
Code added date: 20190701.
Code effective date: 20190701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7680 - Terbutaline sulf comp con
Long description: Terbutaline sulfate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
Code added date: 20000101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7681 - Terbutaline sulf comp unit
Long description: Terbutaline sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
Code added date: 20000101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7682 - Tobramycin non-comp unit
Long description: Tobramycin, inhalation solution, fda-approved final product, non-compounded, unit dose form, administered through dme, per 300 milligrams
Code added date: 20000101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF